COM:ROYALTYPHARMA

Royalty Pharma

Stock

Last Close

26.22

21/11 19:29

Market Cap

11.63B

Beta: -

Volume Today

1.83M

Avg: -

Overview Analysis Metrics Financials Filings people API Chart Data

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Dec '17	Dec '18	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23
revenue	1.60B -	1.79B 12.33%	1.81B 1.08%	2.12B 16.96%	2.29B 7.89%	2.24B 2.28%	2.35B 5.24%
cost of revenue		135.96M -		88.11M -	23.00M 73.90%	5.67M 75.34%
gross profit	1.60B -	1.66B 3.82%	1.81B 9.36%	2.03B 12.11%	2.27B 11.44%	2.23B 1.54%	2.35B 5.51%
selling and marketing expenses
general and administrative expenses	106.44M -	61.91M 41.84%	103.44M 67.09%	182M 75.95%	182.83M 0.45%	227.30M 24.33%	249.75M 9.87%
selling general and administrative expenses	106.44M -	61.91M 41.84%	103.44M 67.09%	182M 75.95%	182.83M 0.45%	227.30M 24.33%	249.75M 9.87%
research and development expenses	117.87M -	392.61M 233.10%	83.04M 78.85%	26M 68.69%	200.08M 669.55%	177.11M 11.48%	52M 70.64%
other expenses	-1.62M -	-1.52M 6.18%	-995.40M 65,472.92%	319M 132.05%	475.84M 49.17%	909.91M 91.22%	-560.66M 161.62%
cost and expenses	658.24M -	430.45M 34.61%	-808.92M 287.93%	527M 165.15%	858.75M 62.95%	1.31B 53.05%	862.40M 34.38%
operating expenses	658.24M -	430.45M 34.61%	-808.92M 287.93%	527M 165.15%	858.75M 62.95%	1.31B 53.05%	862.40M 34.38%
interest expense	247.34M -	279.96M 13.19%	268.57M 4.07%	157M 41.54%	166.14M 5.82%	187.96M 13.13%	187.19M 0.41%
ebitda	1.14B -	1.41B 23.80%	2.64B 86.56%	1.88B 28.64%	1.48B 21.25%	983.17M 33.66%	1.49B 51.77%
operating income	939.69M -	1.36B 45.20%	2.62B 92.25%	1.59B 39.20%	1.43B 10.30%	977.50M 31.68%	1.49B 52.65%
depreciation and amortization	33.27M -	33.27M 0%	14.13M 57.53%	287M 1,931.28%	51.36M 82.10%	5.67M 88.96%
total other income expenses net	644.07M -	408.92M 36.51%	-161.76M 139.56%	107M 166.15%	-189.51M 277.12%	-747.43M 294.40%	207.94M 127.82%
income before tax	1.34B -	1.52B 13.00%	2.46B 62.16%	1.70B 30.85%	1.24B 27.07%	230.06M 81.46%	1.70B 638.96%
income tax expense	542.65M -	433.37M 20.14%	349.33M 19.39%	1.15B 228.34%	762.45M 33.53%	187.23M 75.44%	565.25M 201.90%
net income	1.21B -	1.38B 13.86%	2.35B 70.46%	555M 76.37%	478.75M 13.74%	42.83M 91.05%	1.13B 2,549.50%
weighted average shs out	354.18M -	354.18M 0%	354.18M 0%	375.44M 6.01%	414.79M 10.48%	437.96M 5.59%	602.90M 37.66%
weighted average shs out dil	354.18M -	354.18M 0%	354.18M 0%	375.45M 6.01%	414.80M 10.48%	437.97M 5.59%	602.90M 37.66%
eps	3.42 -	3.89 13.74%	6.63 70.44%	1.48 77.68%	1.15 22.30%	0.10 91.48%	2.54 2,491.84%
epsdiluted	3.42 -	3.89 13.74%	6.63 70.44%	1.48 77.68%	1.15 22.30%	0.10 91.48%	2.53 2,481.63%

All numbers in (except ratios and percentages)